天益医疗
(301097)
| 流通市值：7.93亿 | | | 总市值：25.47亿 |
| 流通股本：1834.74万 | | | 总股本：5894.74万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 227,316,427.9 | 98,512,592.7 | 418,956,783.24 | 311,778,533.86 |
| 营业收入 | 227,316,427.9 | 98,512,592.7 | 418,956,783.24 | 311,778,533.86 |
| 二、营业总成本 | 219,893,806.54 | 98,982,139.54 | 429,024,625.99 | 314,441,721.66 |
| 营业成本 | 146,658,398.92 | 65,755,487.02 | 268,620,201.7 | 202,962,437.5 |
| 税金及附加 | 3,442,900.38 | 1,516,388.57 | 5,793,729.07 | 4,128,092.9 |
| 销售费用 | 12,436,751.48 | 5,484,694.67 | 20,344,953.41 | 11,077,896.04 |
| 管理费用 | 36,126,152.96 | 15,609,952.7 | 87,046,331.14 | 57,978,609.62 |
| 研发费用 | 23,706,008.83 | 11,762,426.61 | 60,470,862.37 | 38,465,067.26 |
| 财务费用 | -2,476,406.03 | -1,146,810.03 | -13,251,451.7 | -170,381.66 |
| 其中:利息费用 | 5,927,102.06 | 2,903,160.97 | 9,777,138.63 | 7,959,055.51 |
| 其中:利息收入 | 8,314,464.81 | 4,013,253.24 | 16,108,825.52 | 10,370,589.77 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,557,015.08 | 1,197,381.14 | 4,219,139.47 | 659,327.9 |
| 加:投资收益 | -24,840.2 | 2,906,880.51 | 5,322,130.69 | 4,623,066.24 |
| 资产处置收益 | 272,048.53 | 228.62 | -222,477.91 | -221,061.98 |
| 资产减值损失(新) | -1,366,545.03 | -17,524.54 | -2,266,288.28 | -910,276.04 |
| 信用减值损失(新) | -2,018,732.11 | 472,512.54 | -4,037,829.28 | 13,248.81 |
| 其他收益 | 4,332,754.24 | 1,013,466.82 | 3,907,809.1 | 3,392,957.39 |
| 四、营业利润 | 10,174,321.87 | 5,103,398.25 | -3,145,358.96 | 4,894,074.52 |
| 加:营业外收入 | 14,388.66 | 12,765.62 | 40,158.17 | 51,453.3 |
| 减:营业外支出 | 539,409.15 | 35,471.7 | 31,275.67 | 21,056.81 |
| 五、利润总额 | 9,649,301.38 | 5,080,692.17 | -3,136,476.46 | 4,924,471.01 |
| 减:所得税费用 | -643,223.08 | 204,573.51 | 3,088,457.07 | 2,429,459.26 |
| 六、净利润 | 10,292,524.46 | 4,876,118.66 | -6,224,933.53 | 2,495,011.75 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 10,292,524.46 | 4,876,118.66 | -6,224,933.53 | 2,495,011.75 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 9,483,233.38 | 4,876,118.66 | -743,965.6 | 6,342,584.65 |
| 少数股东损益 | 809,291.08 | - | -5,480,967.93 | -3,847,572.9 |
| 扣除非经常损益后的净利润 | 1,039,300.99 | -520,711.29 | -10,413,100.82 | -1,269,562.71 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.16 | 0.08 | -0.01 | 0.11 |
| (二)稀释每股收益 | 0.16 | 0.08 | -0.01 | 0.11 |
| 八、其他综合收益 | 1,811,581.31 | 2,123,409.23 | -1,240,594.67 | -274,399.01 |
| 归属于母公司股东的其他综合收益 | 1,811,581.31 | 2,123,409.23 | -488,803.7 | -239,782.61 |
| 九、综合收益总额 | 12,104,105.77 | 6,999,527.89 | -7,465,528.2 | 2,220,612.74 |
| 归属于母公司股东的综合收益总额 | 11,294,814.69 | 6,999,527.89 | -1,232,769.3 | 6,102,802.04 |
| 归属于少数股东的综合收益总额 | 809,291.08 | - | -6,232,758.9 | -3,882,189.3 |
| 公告日期 | 2025-08-28 | 2025-04-28 | 2025-04-15 | 2024-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |